CanBas Co (TSE:4575) ROE % Adjusted to Book Value : -23.53% (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is CanBas Co ROE % Adjusted to Book Value?

CanBas Co's ROE % for the quarter that ended in Jun. 2024 was -98.34%. CanBas Co's PB Ratio for the quarter that ended in Jun. 2024 was 4.18. CanBas Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -23.53%.

CanBas Co ROE % Adjusted to Book Value Historical Data

The historical data trend for CanBas Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanBas Co ROE % Adjusted to Book Value Chart

CanBas Co Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.81

-19.67

-8.32

-10.92

-13.55

CanBas Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-11.14	-5.89	-4.72	-7.44	-23.53

Competitive Comparison of CanBas Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, CanBas Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanBas Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CanBas Co's ROE % Adjusted to Book Value falls into.

CanBas Co ROE % Adjusted to Book Value Calculation

CanBas Co's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-56.62%	/	4.18
	=	-13.55%

CanBas Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-98.34%	/	4.18
	=	-23.53%

CanBas Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CanBas Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CanBas Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CanBas Co Ltd (TSE:4575) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Toriyoko-cho, Shizuoka, JPN, 410-0891

Website

http://www.canbas.co.jp

CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.

CanBas Co Headlines

No Headlines